Top news
COVID-19 Vaccine Monitor: October 2021 | KFF
By Liz Hamel, Audrey Kearney & Brodie Mollyann
After J&J, more people 'mix and match' with Pfizer or Moderna booster
By Kaitlin Sullivan & Elliott Ramos
France becomes latest European nation telling people under age 30 NOT to get the Moderna vaccine
By Mansur Shaheen
All coverage
'Strong' start to kids vaccine campaign, but challenges loom
By Mike Stobbe & Zeke Miller
Germany recommends only Biontech/Pfizer vaccine for under-30s
By Riham Alkousaa
Stunning Vaccine Stat: 98.5% Of U.S. Seniors Have Had Shot
By Alison Durkee
Moderna disputes NIH invention of covid vaccine
By Christopher Rowland
Nearly 1 million kids ages 5-11 will have their first COVID shots by the end of today
By Tamara Keith
New data says you should get a Covid vaccine booster shot as soon as you're eligible — here's why
By Cory Stieg
How to choose a COVID-19 vaccine booster shot
By Tina Hesman Saey
Covid-19 booster shots: what we know about immunity, availability, and eligibility
By Mr.Germán López-Espinosa
What pediatricians want parents to know about the Covid vaccine for kids
By Jacqueline Stenson
French health authority advises against Moderna COVID-19 vaccine for under 30s
By Louise Heavens & Tassilo Hummel
Moderna says Covid vaccine has fewer breakthrough cases than Pfizer's, but higher myocarditis rates in young men
By Berkeley Lovelace & Berkeley Lovelace Jr.
White House says about 900,000 kids ages 5 to 11 got a Covid vaccine in the first week after its approval
By Berkeley Lovelace & Berkeley Lovelace Jr.
Moderna and U.S. at Odds Over Vaccine Patent Rights (Published 2021)
By Rebecca Robbins & Sheryl Gay Stolberg
White House Estimates Almost 1 Million Younger Children Got Vaccines So Far
By Sheryl Gay Stolberg
N.I.H. Says It Is Not Giving Up in Patent Fight with Moderna
By Sheryl Gay Stolberg & Rebecca Robbins